Sandra Zlamal-Fortunat
Overview
Explore the profile of Sandra Zlamal-Fortunat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
10
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kietaibl A, Schutz-Fuhrmann I, Bozkurt L, Fruhwald L, Rami-Merhar B, Frohlich-Reiterer E, et al.
Wien Klin Wochenschr
. 2024 Aug;
136(Suppl 9):467-477.
PMID: 39196351
People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic...
2.
Schutz-Fuhrmann I, Rami-Merhar B, Frohlich-Reiterer E, Hofer S, Tauschmann M, Mader J, et al.
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):53-61.
PMID: 37101025
This Guideline represents the recommendations of the Austrian Diabetes Association (ÖDG) on the use of diabetes technology (insulin pump therapy; continuous glucose monitoring, CGM; hybrid closed-loop systems, HCL; diabetes apps)...
3.
Clodi M, Abrahamian H, Brath H, Schernthaner G, Brix J, Ludvik B, et al.
Wien Klin Wochenschr
. 2023 Apr;
135(Suppl 1):32-44.
PMID: 37101023
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy...
4.
Schutz-Fuhrmann I, Rami-Merhar B, Hofer S, Frohlich-Reiterer E, Mader J, Stadler M, et al.
Wien Klin Wochenschr
. 2019 Apr;
131(Suppl 1):119-123.
PMID: 30980171
This position statement represents the recommendations of the Austrian Diabetes Association regarding the clinical diagnostic and therapeutic application, safety and benefits of continuous subcutaneous glucose monitoring systems in patients with...
5.
Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, et al.
Wien Klin Wochenschr
. 2019 Apr;
131(Suppl 1):27-38.
PMID: 30980148
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy...
6.
Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, et al.
Wien Klin Wochenschr
. 2019 Apr;
131(Suppl 1):39-46.
PMID: 30980147
The present article is a recommendation of the Austrian Diabetes Association for the practical use of insulin in type 2 diabetes, including the various insulin regimens.
7.
Schutz-Fuhrmann I, Stadler M, Zlamal-Fortunat S, Rami-Merhar B, Frohlich-Reiterer E, Hofer S, et al.
Wien Klin Wochenschr
. 2019 Apr;
131(Suppl 1):47-53.
PMID: 30980146
This position statement is based on current evidence available on the safety and benefits of continuous subcutaneous insulin infusion therapy (CSII, pump therapy) in diabetes with an emphasis on the...
8.
Stadler M, Zlamal-Fortunat S, Schutz-Fuhrmann I, Rami-Merhar B, Frohlich-Reiterer E, Hofer S, et al.
Wien Klin Wochenschr
. 2016 Apr;
128 Suppl 2:S188-95.
PMID: 27052245
This position statement is based on the current evidence available on the safety and benefits of continuous subcutaneous insulin pump therapy (CSII) in diabetes with an emphasis on the effects...
9.
Schutz-Fuhrmann I, Rami-Merhar B, Hofer S, Stadler M, Bischof M, Zlamal-Fortunat S, et al.
Wien Klin Wochenschr
. 2016 Apr;
128 Suppl 2:S184-7.
PMID: 27052243
This position statement represents the recommendations of the Austrian Diabetes Association regarding the clinical diagnostic and therapeutic application, safety and benefits of continuous subcutaneous glucose monitoring systems in patients with...
10.
Weitgasser R, Abrahamian H, Clodi M, Zlamal-Fortunat S, Hammer H
Wien Klin Wochenschr
. 2016 Apr;
128 Suppl 2:S163-6.
PMID: 27052236
Exocrine pancreatic insufficiency (EPI) in diabetic patients is frequent. Studies based on fecal elastase-1 measurement give prevalence rates of 10‒30 % of severe and 22‒56 % of moderate EPI in...